查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466134

临床试验供应和物流市场：按服务、按类型、按阶段、按治疗领域、按最终用户 - 2024-2030 年全球预测

Clinical Trial Supply & Logistics Market by Services (Comparator Sourcing, Logistics & Distribution, Manufacturing), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, Therapeutic Area, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年临床试验供应和物流市场规模预计为243.3亿美元，预计2024年将达262亿美元，2030年将达到410.4亿美元，复合年增长率为7.75%。

临床试验供应和物流包括进行临床试验所需的临床试验材料 (CTM) 的规划、管理、储存和分发。这些材料包括临床实验药品 (IMP)、安慰剂、病患套件、辅助用品、标籤服务等。 CTSL 的主要目标是按照良好生产规范 (GMP) 和良好分销规范 (GDP) 有效地进行临床试验，同时保持产品品质和完整性。慢性病的流行以及政府对药物研发过程的投资不断增加正在推动临床试验用品和物流的使用。另一方面，临床试验的高昂成本和训练有素的专家数量有限正在阻碍市场成长。然而，人们对药物开发计划的兴趣日益浓厚，再加上临床试验的外包，预计未来几年其使用量将会增加。

主要市场统计
基准年[2023] 243.3亿美元
预测年份 [2024] 262亿美元
预测年份 [2030] 410.4亿美元
复合年增长率（%） 7.75%

低温运输配送服务不断进步，服务需求增加

比较药物采购是临床试验的一个重要方面，供应链管理公司从值得信赖和核准的供应商采购必要的药物和其他材料，以及采购临床实验药物和参考材料。此过程在不同地点和国家的临床实验期间维持标准供应。采购比较器有助于保持测试结果的一致性，同时避免因产品或其品质的变化而导致的潜在混淆。物流与配送管理临床实验药物到不同地区多个研究地点的运输与交付。这包括协调海关程序、监控每个国家的监管合规要求以及确保必要时的低温运输储存。製造是指临床试验材料的製造，包括活性药物成分（API）、赋形剂、药品和安慰剂製剂。生产过程必须遵守监管机构制定的严格的良好生产规范 (GMP) 准则，以确保在整个测试期间始终生产出高品质的产品。包装、标籤和致盲服务负责准备最终临床试验材料以运送到研究机构。包装涉及根据特定方案要求创建单位剂量包装或散装包装，同时在运输过程中保持适当的环境条件。标籤涉及在包装上列印准确的信息，例如剂量、储存说明、有效期限和唯一识别码。盲法是指向试验参与者、临床实验和现场工作人员隐藏治疗分配的过程，以避免试验结果中潜在的偏差。储存和保存服务涵盖临床试验材料整个生命週期的安全存储，从最初到达储存设施到最终销毁，包括提供适当的温度控制环境，这包括确保维护、遵守材料处理的监管指南、并限制授权负责人的访问。

类型：小分子在製药领域的使用快速增加

在临床试验供应和物流中，生物製药、医疗设备和小分子提供了针对特定医疗需求和治疗目标的独特优势。生物製药（生物製药）是透过活体生物体开发的，因其能够精确靶向病变细胞而受到青睐。儘管需要复杂的製造和低温运输管理，我们仍为传统治疗方法不足以治疗的疾病提供副作用最小的有效治疗方法。医疗设备包括简单的工具和复杂的系统，例如核磁共振造影系统，它们作为非侵入性诊断和治疗选择而受到青睐，行业领导者得到了物流公司的支持。小分子药物的特征是分子量小，易于渗透到细胞中，由于其多功能性和易于给药而变得极为重要。生物製药、设备或小分子之间的选择取决于所解决的特定健康状况、治疗和研究目标以及物流考虑，这些因素可用于推进患者照护和临床研究，需要强调的是，它们发挥着互补作用。

扩大三期临床试验的供应与物流服务范围

生物有效性测试确定活性成分或治疗化合物渗透作用部位并变得可用的速率和程度。生物等效性测试比较两种药物之间的生物利用度。这些测试对于学名药的开发至关重要。第一阶段临床试验是新药首次应用于人体的试验，通常由少数健康志愿者进行。主要目的是评估安全性、耐受性、药物动力学和动态。第二阶段试验将测试该药物的有效性并继续评估其安全性。研究族群通常包括患有所研究的病症或疾病的患者。第三阶段试验涉及大量患者，以确认药物的有效性、监测副作用、与常用的治疗方法进行比较，并收集安全使用药物的资讯。第四阶段（上市后监测）是药物被核准向消费者销售后的持续调查。它的目的是检测罕见和长期的副作用，并比较常用药物的有效性。

治疗领域：扩大私营和公共部门在癌症领域的投资和研究活动

在处理血液样本等敏感生物材料时，血液疾病临床试验用品和物流需要仔细协调。此类测试通常需要专门的储存和及时的运输，以确保样品的完整性以获得准确的测试结果。心血管疾病临床实验需要对临床实验药物进行严格的控制和监测。鑑于这些疾病的高发病率，临床实验广泛，需要可扩展的物流解决方案来有效管理临床实验成分的分配。由于临床实验药物的敏感性，中枢神经系统和精神疾病领域的临床试验需要创新的物流解决方案。其中包括需要特殊处理、分配通讯协定和严格遵守法规的受管制物质。涉及皮肤病的临床实验通常需要多种剂型，包括外用和口服药物，需要客製化的物流策略。快速且准确的物流对于维持这些产品在不同气候和地区的有效性至关重要。消化器官系统疾病临床实验要求供应链善于处理从酵素到益生菌的各种临床实验药物，并特别注意在不同的储存条件下维持产品的稳定性和完整性。耳鼻喉科临床试验物流重点在于专业设备和药物的分配，以确保及时运送到临床试验地点。遵守特定的储存说明对于保持这些物品的有效性至关重要。免疫学测试通常涉及生技药品的使用，这需要低温运输物流和先进的监控以防止劣化。此类临床试验的全球性使运输变得复杂，并且需要强大的追踪和温度控制系统。由于感染疾病需要新的治疗方法，特别是在大流行情况下，临床实验药物供应物流的重点是快速扩充性和分配。此类治疗药物的安全、快速运输机制对于在实验室和临床实验试验地点之间运输敏感材料至关重要。

代谢疾病临床试验需要处理多种临床实验药物，并且通常需要客製化的物流解决方案。注意运输和储存条件的细节对于确保这些化合物的完整性至关重要。剂量准确性和时间安排在肾臟相关试验中至关重要，因此透过先进的追踪和物流规划来精确管理药物和设备至关重要。肿瘤临床试验是最复杂的临床试验之一，通常需要针对个别患者进行高度专业化的治疗。这需要灵活、快速的物流系统，能够在恶劣的条件下处理包括活细胞在内的精緻材料。

此外，罕见疾病临床试验为供应链带来了独特的挑战，因为患者数量通常有限且地理位置分散。客製化的物流解决方案对于满足临床试验的独特需求和紧急情况至关重要。此外，呼吸系统疾病临床实验需要物流系统容纳各种临床实验药物，包括吸入器和雾化器，确保精确的温度控制和快速的通路，以确保交付时的产品功效。

最终用户：製药和生物技术公司更多地使用临床试验用品和物流

合约委外研发机构(CRO) 依靠临床试验供应和物流服务在临床试验的所有阶段提供端到端支援。合作伙伴关係为 CRO 提供了一个灵活的供应链，以确保及时向临床实验试验地点交付临床实验药品 (IMP)、辅助材料和设备。此外，这些服务还帮助 CRO 在受控环境中管理对温度敏感的货运，并即时监控世界各地仓库的存量基准。医疗设备製造商依靠临床试验供应和物流服务来有效管理复杂的供应链要求。透过利用专业物流提供者的专业知识，医疗设备製造商可以在运输过程中保持适当的储存条件，遵守进出口法规，并降低与全球器械分销相关的风险。製药和生物技术公司严重依赖临床试验供应和物流服务来满足其临床试验需求。这些服务有助于管理临床实验生物药品的整个供应链，包括製造、包装、标籤、分销、储存和销毁。由于生物製药的脆弱性和脆弱性，製药和生物技术公司需要专门的物流解决方案来保持产品在运输过程中的稳定性。此外，这些服务还可以利用需求预测工具和实施准时制(JIT) 策略，帮助製药和生物技术公司优化其供应链、最大限度地减少浪费并消除过剩库存，并有助于降低与缺货商品相关的价格。

区域洞察

在美洲地区，北美拥有重要的临床试验供应和物流，其中美国凭藉强大的製药业和大量研发投资引领成长。此外，大量大型製药企业进行临床试验以及政府对研发活动的大力支持正在支持市场扩张。由于南美洲不断发展的医疗基础设施和对临床研究的日益关注，也促进了临床试验用品和物流的使用增加。由于中国、印度、韩国、台湾、印尼和越南等国家製药业的快速发展，亚太地区临床试验用品和物流市场正在快速成长。此外，由于资源丰富且价格具竞争力，许多跨国製药公司正在该地区建立研发中心或与当地合作伙伴合作。在EMEA（欧洲、中东和非洲）地区，欧洲由于拥有大量的製药和生物技术公司，传统上被认为是全球临床试验供应和物流市场的据点。欧盟 (EU) 已建立了在成员国之间进行临床试验的框架，以确保临床实验药品 (IMP) 的安全性、有效性和品质。此外，中东和非洲是欧洲、中东和非洲地区的新兴市场。其中包括政府增加医疗保健支出、跨国製药公司开拓市场以扩大有资格获得临床实验药物和医疗设备的患者数量、医疗保健基础设施的持续发展以及透过教育投资确保熟练的劳动力。

FPNV定位矩阵

FPNV 定位矩阵对于评估临床试验供应和物流市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对临床试验供应和物流市场中供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，以获得市场竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.临床试验供应和物流市场的市场规模和预测是多少？

2.在临床试验供应和物流市场的预测期间内，有哪些产品、细分市场、应用和领域需要考虑投资？

3.临床试验供应和物流市场的技术趋势和法规结构是什么？

4.临床试验供应和物流市场主要供应商的市场占有率是多少？

5. 进入临床试验供应及物流市场的适当型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 随着慢性病发病率上升，政府增加资金以加强整个经济领域的药物研发活动
      • 临床试验的全球化与法规的统一
    • 抑制因素
      • 与技术整合和资料管理相关的问题
    • 机会
      • 整合人工智慧和机器学习以进行供应链优化中的预测分析
      • 药厂和 CDMO 之间的合作活动增加
    • 任务
      • 与临床试验供应和物流业务相关的担忧
  • 市场区隔分析
    • 服务：低温运输配送服务随着需求的成长而不断发展
    • 类型：小分子在医药领域的使用快速增加
    • 阶段：扩大3期临床试验供应与物流服务范围
    • 治疗领域：私营和公共部门在肿瘤学方面的投资和研究活动激增
    • 最终用户：製药和生物技术公司更多地使用临床试验用品和物流
  • 市场趋势分析
    • 整合美洲供应链强大的药品生产能力和先进技术
    • 扩大医疗保健产业和政府支持措施加强全部区域亚太地区的临床试验物流
    • 市场参与者实力雄厚，并持续专注于发展全部区域的药品供应链
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析
  • 客户客製化
    • Catalent, Inc.：积极参与网路研讨会和会议，推广临床试验供应和物流方面的创新解决方案和服务。
    • Infosys Limited：专注于渗透定价策略，以低价提供解决方案，同时确保高精度和高品质
    • Almac 集团：Marken 发起新的行销宣传活动以促进临床药品的储存和分销
    • Eurofins Scientific Group：Eurofins Scientific Group 专注于会议和展览，以实现有效的产品行销。
    • Lonza Group AG：Lonza Group AG 加强全球扩张的关键数位行销策略
    • 生物药品：利用数位技术简化供应链、提高透明度并改善与相关人员的沟通
    • 医疗设备：普及解决相关人员担忧的教育内容
    • 小分子：解决激烈竞争和监管复杂性的需要
    • 临床试验供应及物流服务采取多元化行销策略

第六章临床试验供应与物流市场：依服务分类

  • 比较采购
  • 物流/配送
  • 製造业
  • 包装、标籤和致盲
  • 储存和保留

第七章临床试验用品和物流市场：按类型

  • 生物製药
  • 医疗设备
  • 小分子

第八章临床试验供应及物流市场分阶段

  • 学士/工学士研究
  • 阶段1
  • 阶段2
  • 第三阶段
  • 第四阶段

第九章依治疗领域分類的临床试验供应及物流市场

  • 血液疾病
  • 心血管疾病
  • 中枢神经系统和精神障碍
  • 皮肤病
  • 消化系统疾病
  • 耳鼻喉科疾病
  • 免疫学
  • 感染疾病
  • 代谢紊乱
  • 肾臟病学
  • 肿瘤学
  • 罕见疾病
  • 呼吸系统疾病

第10章临床试验供应与物流市场：依最终使用者分类

  • 合约调查机构
  • 医疗设备公司
  • 製药和生物技术公司

第十一章美洲临床试验供应及物流市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太临床试验供应及物流市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲临床试验供应及物流市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • PCM Trials 收购荷兰临床试验服务
    • Piramal Pharma Solutions 庆祝在苏格兰格兰奇茅斯开设 ADC 製造厂
    • Biocare 宣布美国扩张作为全球成长策略的一部分
    • Vaxcyte 与 Lonza 签署新的 PCV 商业製造协议
    • Piramal Pharma Solutions 在艾哈默德巴德的 Discovery Services 地点推出体外生物学功能
    • Signant Health 成立 Signant Biotech，以加速和简化新兴生物製药公司的临床开发
    • N-SIDE 推出革命性软体 Lighthouse，塑造全球临床试验供应管理的未来
    • Zuellig Pharma 与 GSK 在新加坡建立疫苗分销中心
    • Alyceum Therapeutics 与 Eurofins CDMO 签署医药多计划协议
    • Vial宣布与皇家国际集团建立策略伙伴关係
    • Biocair 与 TrakCel 合作提高供应链视觉性
    • IDEAYA 扩大与辉瑞的临床试验合作和供应协议
    • 康泰伦特开始斥资 2,000 万美元扩建德国临床供应设施
    • Eurofins Biopharma 产品测试 ENCO 扩大在美国的产能
    • Calyx推出新的临床试验供应预测服务
    • 康泰伦特完成新加坡临床供应设施扩建，以提高温度控制能力
    • PAREXEL 在中国苏州开设临床试验用品和物流仓库

第15章竞争组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-501246436315

[196 Pages Report] The Clinical Trial Supply & Logistics Market size was estimated at USD 24.33 billion in 2023 and expected to reach USD 26.20 billion in 2024, at a CAGR 7.75% to reach USD 41.04 billion by 2030.

Clinical trial supply & logistics encompasses the planning, management, storage, and distribution of clinical trial materials (CTMs) needed to conduct clinical studies. These materials include investigational medicinal products (IMPs), placebos, patient kits, ancillary supplies, and labeling services. The main objective of CTSL is to ensure that clinical trials are conducted efficiently and in compliance with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) guidelines while maintaining product quality and integrity. The prevalence of chronic disorders and increasing government investments in pharmaceutical research & development process drives the use of clinical trial supply & logistics. On the contrary, the cost-intensive nature of clinical trials and the limited availability of trained professionals hinders market growth. However, growing interest in drug development projects coupled with outsourcing clinical trials is expected to increase its usage in the coming years.

KEY MARKET STATISTICS
Base Year [2023] USD 24.33 billion
Estimated Year [2024] USD 26.20 billion
Forecast Year [2030] USD 41.04 billion
CAGR (%) 7.75%

Services: Continuous advancements in cold chain distribution services with growing demand

Comparator sourcing is a crucial aspect of clinical trials where supply chain management companies source the required drugs and other materials from reliable and approved sources, which involves procuring investigational and reference products. The process ensures that standardized supplies are maintained throughout the trial period across different sites and countries. Comparator sourcing helps maintain consistency in trial results while avoiding any potential disruptions due to variations in products or their quality. Logistics & distribution encompasses the management of transportation and delivery of clinical trial materials to multiple research sites across various regions. This includes coordinating with customs clearance procedures, monitoring regulatory compliance requirements for each country, and ensuring cold chain storage is maintained if necessary. Manufacturing refers to the production of clinical trial materials, including active pharmaceutical ingredients (APIs), excipients, drug products, and placebo formulations. Manufacturing processes must adhere to strict Good Manufacturing Practices (GMP) guidelines set by regulatory authorities to ensure high-quality products are produced consistently throughout the entire study period. Packaging, labeling, and blinding services deal with preparing the final clinical trial materials for shipment to research sites. Packaging involves creating unit dose packs or bulk packaging according to specific protocol requirements while maintaining appropriate environmental conditions during transport. Labeling includes printing accurate information on packages, such as dosage strength, storage instructions, expiry date(s), and unique identification codes. Blinding refers to the process of concealing treatment allocations from trial participants, investigators, and site staff to avoid any potential biases in the results. Storage & retention services cover the secure housing of clinical trial materials throughout their entire lifecycle, from initial arrival at storage facilities until final destruction, including maintaining appropriate temperature-controlled environments, adhering to regulatory guidelines on material handling, and ensuring that limited access is granted to authorized personnel.

Type: Surging utilization of small molecules in the pharmaceutical sector

In clinical trial supplies & logistics, biological drugs, medical devices, and small molecules present unique advantages tailored to specific medical needs and treatment objectives. Biologic drugs, or biopharmaceuticals, developed through living organisms, are preferred for their precise ability to target diseased cells. They offer effective treatments with minimal side effects for conditions where traditional therapies fall short despite their need for complex manufacturing and cold chain management. Medical devices include simple tools, advanced systems, such as MRI machines, favored for their non-invasive diagnostics and treatment options, with industry giants supported by logistic companies. Small molecules, characterized by their low molecular weight and ease of penetration into cells, are pivotal for their versatility and ease of administration. The selection among biologics, devices, or small molecules hinges on the specific health condition being addressed, the goals of treatment or research, and logistical considerations, highlighting the diverse and complementary roles they play in advancing patient care and clinical research.

Phase: Increasing scope of supply & logistics services in phase 3 clinical trials

Bioavailability studies determine the rate and extent to which the active ingredient or therapeutic compound is soaked and becomes available at the site of action. Bioequivalence studies compare the bioavailability between two pharmaceutical products. These studies are crucial in the development of generic drugs. Phase 1 trials are the initial infusion of a new drug into humans, typically conducted with a few healthy volunteers. The primary goal is to assess safety, tolerability, pharmacokinetics, and pharmacodynamics. Phase 2 trials test the efficacy of a drug and continue to evaluate its safety. The study population typically includes patients with the condition or disease being studied. Phase 3 trials involve large groups of patients and aim to confirm a drug's efficacy, monitor side effects, compare it to typically used treatments, and gather information that allows the drug to be used safely. Phase 4, or post-marketing surveillance, involves the ongoing study of a drug after it has been approved for consumer sale. It aims to detect rare or long-term adverse effects and compare the drug's effectiveness in general use.

Therapeutic Area: Proliferating private and public sector investments and research activities in oncology

In clinical trial supply & logistics for blood disorders, meticulous coordination is essential to handle sensitive biological materials, such as blood samples. These trials often require specialized storage and timely transportation to ensure sample integrity for accurate trial outcomes. Supply chain management for cardiovascular disease trials necessitates rigorous control and monitoring of investigational medicinal products. Trials are extensive and require scalable logistics solutions to manage trial component distribution efficiently, considering the high prevalence of these diseases. Clinical trials in the CNS and mental disorder domain necessitate innovative logistic solutions owing to the sensitive nature of investigational drugs. These include controlled substances requiring specialized handling, distribution protocols, and stringent regulatory compliance. Trials involving dermatological disorders often necessitate diverse product forms, including topicals and orals, requiring customized logistics strategies. Quick and precise distribution is vital to maintain the efficacy of these products across various climates and regions. For digestive disorder trials, the supply chain should be adept at handling various investigational products, from enzymes to probiotics, with special attention to maintaining product stability and integrity under different storage conditions. Supply logistics for ENT disease trials focus on the distribution of specialized devices and medication, ensuring timely delivery to trial sites. It's crucial to adhere to specific storage instructions to preserve the effectiveness of these items. Immunology trials often involve biologics that require cold chain logistics and advanced monitoring to guard against degradation. The global nature of these trials adds complexity to shipping and requires robust systems for tracking and temperature management. Trial supply logistics are focused on rapid scalability and distribution with the need for new treatments in infectious diseases, especially in pandemic situations. Secure and quick transport mechanisms for such therapeutics are critical for moving sensitive materials between labs and trial sites.

Clinical trials for metabolic disorders require handling a broad spectrum of investigational products, often necessitating personalized logistics solutions. Attention to detail in shipping and storage conditions is paramount to ensure the integrity of these compounds. Given the importance of dose accuracy and timing in nephrology-related trials, ensuring the precise management of medications and devices with advanced tracking and logistical planning is essential. Oncology trials are among the most complex, requiring highly specialized treatments often tailored to individual patients. This necessitates a flexible and responsive logistics system that handles sensitive materials, including live cells, under strict conditions.

Moreover, clinical trials for rare diseases present unique supply chain challenges due to the often-limited patient population and scattered geographical distribution. Tailored logistics solutions are essential to address these trials' specific needs and urgency. Furthermore, in trials for respiratory disorders, logistical systems must accommodate a range of investigational products, including inhalers and nebulizers, requiring precise temperature control and swift distribution channels to ensure product efficacy upon delivery.

End User: Rising use of clinical trial supply & logistics by pharmaceutical & biotechnology companies

Contract research organizations (CROs) rely on clinical trial supply & logistics services to provide end-to-end support throughout all stages of clinical trials. Through partnerships, CROs can access flexible supply chains, ensuring timely delivery of investigational medicinal products (IMP), ancillary materials, and devices to trial sites. Moreover, these services help CROs manage temperature-sensitive shipments through controlled environments and monitor real-time inventory levels at depots worldwide. Medical device companies utilize clinical trial supply & logistics services to manage their complex supply chain requirements efficiently. Medical device companies can maintain proper storage conditions during transportation, adhere to import/export regulations, and reduce risks associated with global device distribution by leveraging specialized logistics providers' expertise. Pharmaceutical & biotechnology companies heavily depend on clinical trial supply & logistics services for their clinical trial needs, and these services assist in managing the entire supply chain of investigational biopharmaceutical products, including manufacturing, packaging, labeling, distribution, storage, and destruction. Pharmaceutical & biotechnology companies require specialized logistics solutions to maintain product stability during transportation owing to biopharmaceutical products' fragile and sensitive nature. Furthermore, these services help pharmaceutical & biotechnology companies optimize their supply chains by utilizing demand forecasting tools and implementing just-in-time (JIT) strategies to minimize wastage and reduce prices associated with overstocking or stockouts.

Regional Insights

In the Americas region, North America has considerable utilization of clinical trial supply & logistics, with the United States leading the growth with its robust pharmaceutical industry and extensive investment in research and development (R&D). Furthermore, numerous leading pharmaceutical companies conducting clinical trials and strong government support for R&D activities drive market expansion. South America also contributes to increasing clinical trial supply & logistics usage due to its developing healthcare infrastructure and growing focus on clinical research. The Asia-Pacific region's clinical trial supply & logistics market is growing rapidly due to its rapidly evolving pharmaceutical industry in China, India, South Korea, Taiwan, Indonesia, and Vietnam, among others. Moreover, many multinational pharmaceutical companies have established their R&D centers or collaborations with local partners in this region due to resource availability at competitive prices. Within the EMEA region, Europe has been traditionally considered a stronghold for the global clinical trial supply & logistics market due to the presence of numerous pharmaceutical and biotechnology companies. The European Union (EU) has a well-established framework for conducting clinical trials across its member states that ensures the safety, efficacy, and quality of investigational medicinal products (IMPs). In addition, Middle East & Africa are emerging markets within the EMEA region due to increasing healthcare expenditure by governments, expansion of multinational pharmaceutical companies into these markets to tap a larger patient pool for testing their investigational drugs/devices, continuous development of healthcare infrastructure and availability of skilled workforce due to their investments in education.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clinical Trial Supply & Logistics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Trial Supply & Logistics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Supply & Logistics Market, highlighting leading vendors and their innovative profiles. These include Acnos Pharma GmbH, ADAllen Pharma Ltd, Almac Group Limited, Ancillare, LP, Avantor, Inc., Beroe Holdings Inc., Biocair International Limited, Calyx, Catalent, Inc., Clinical Services International LTD, Clinigen Group PLC, COREX LOGISTICS LIMITED, DHL Group, Eurofins Scientific SE, Experic, LLC, FedEx Corporation, ICON PLC, Inceptua S.A., Infosys Limited, IPS Pharma, KLIFO A/S, Lonza Group AG, Marken Limited by United Parcel Service, Inc., Microsoft Corporation, Myonex, Inc., N-SIDE SA, NUVISAN GmbH, OCT Clinical GmbH, Octalsoft, Parexel International Corporation, PCI Pharma Services, PHOENIX Pharmahandel GmbH & Co KG, Piramal Pharma Limited, Recipharm AB, SAP SE, Sharp Services, LLC, Signant Health, SIRO Clinpharm Private Limited, Thermo Fisher Scientific Inc., Tower Cold Chain Solutions, Uniphar PLC, Walden Group, and Zuellig Pharma Pte Ltd by Interpharma Investments Limited.

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Supply & Logistics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Services
    • Comparator Sourcing
    • Logistics & Distribution
      • Cold Chain Distribution
      • Non-Cold Chain Distribution
    • Manufacturing
    • Packaging, Labeling, & Blinding
    • Storage & Retention
  • Type
    • Biologic Drugs
    • Medical Devices
    • Small Molecules
  • Phase
    • BA/ BE studies
    • Phase 1
    • Phase 2
    • Phase 3
    • Phase 4
  • Therapeutic Area
    • Blood Disorders
    • Cardiovascular Diseases
    • CNS & Mental Disorders
    • Dermatological Disorders
    • Digestive Disorders
    • ENT Diseases
    • Immunology
    • Infectious Diseases
    • Metabolic Disorders
    • Nephrology
    • Oncology
    • Rare Diseases
    • Respiratory Disorders
  • End User
    • Contract Research Organisations
    • Medical Devices Companies
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • Massachusetts
        • Minnesota
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Clinical Trial Supply & Logistics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Trial Supply & Logistics Market?

3. What are the technology trends and regulatory frameworks in the Clinical Trial Supply & Logistics Market?

4. What is the market share of the leading vendors in the Clinical Trial Supply & Logistics Market?

5. Which modes and strategic moves are suitable for entering the Clinical Trial Supply & Logistics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising government funds to strengthen pharmaceutical R&D activities across economies with increasing incidence of chronic diseases
      • 5.1.1.2. Globalization of clinical trials and harmonization of regulations
    • 5.1.2. Restraints
      • 5.1.2.1. Problems associated with technology integration and data management
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of artificial intelligence and machine learning for predictive analytics in supply chain optimization
      • 5.1.3.2. Increasing partnership activities between pharmaceutical manufacturers and CDMOs
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with the operations within clinical trial supply and logistics
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Services: Continuous advancements in cold chain distribution services with growing demand
    • 5.2.2. Type: Surging utilization of small molecules in the pharmaceutical sector
    • 5.2.3. Phase: Increasing scope of supply & logistics services in phase 3 clinical trials
    • 5.2.4. Therapeutic Area: Proliferating private and public sector investments and research activities in oncology
    • 5.2.5. End User: Rising use of clinical trial supply & logistics by pharmaceutical & biotechnology companies
  • 5.3. Market Trend Analysis
    • 5.3.1. Strong pharmaceutical production capability and integration of advanced technologies in the supply chain across the Americas
    • 5.3.2. Expanding healthcare sectors coupled with supportive government initiatives augmenting clinical trial logistics across APAC region
    • 5.3.3. Robust presence of market players and continuous focus on advancing pharmaceutical supply chain across EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis
  • 5.8. Client Customization
    • 5.8.1. Catalent, Inc. : Active participation in webinars and conferences to promote innovative solutions and services in clinical trial supply and logistics
    • 5.8.2. Infosys Limited: Focus on penetration pricing strategy to provide solution at a low price while ensuring high precision and quality
    • 5.8.3. Almac Group: Launch of new marketing campaign by Marken Limited to promote clinical drug product storage and distribution
    • 5.8.4. Eurofins Scientific Group: Eurofins Scientific Group's focus on conferences and fairs for effective product marketing
    • 5.8.5. Lonza Group AG: Significant digital marketing strategies by Lonza Group AG to enhance their global reach
    • 5.8.6. Biologic Drugs: Utilisation of digital technologies to streamline the supply chain, enhance transparency, and improve communication with stakeholders
    • 5.8.7. Medical Devices: Disseminating educational content addressing stakeholders' pain points
    • 5.8.8. Small Molecules: Need to address intense competition and regulatory complexities
    • 5.8.9. Adoption of diverse marketing strategies for clinical trial supply & logistics services

6. Clinical Trial Supply & Logistics Market, by Services

  • 6.1. Introduction
  • 6.2. Comparator Sourcing
  • 6.3. Logistics & Distribution
  • 6.4. Manufacturing
  • 6.5. Packaging, Labeling, & Blinding
  • 6.6. Storage & Retention

7. Clinical Trial Supply & Logistics Market, by Type

  • 7.1. Introduction
  • 7.2. Biologic Drugs
  • 7.3. Medical Devices
  • 7.4. Small Molecules

8. Clinical Trial Supply & Logistics Market, by Phase

  • 8.1. Introduction
  • 8.2. BA/ BE studies
  • 8.3. Phase 1
  • 8.4. Phase 2
  • 8.5. Phase 3
  • 8.6. Phase 4

9. Clinical Trial Supply & Logistics Market, by Therapeutic Area

  • 9.1. Introduction
  • 9.2. Blood Disorders
  • 9.3. Cardiovascular Diseases
  • 9.4. CNS & Mental Disorders
  • 9.5. Dermatological Disorders
  • 9.6. Digestive Disorders
  • 9.7. ENT Diseases
  • 9.8. Immunology
  • 9.9. Infectious Diseases
  • 9.10. Metabolic Disorders
  • 9.11. Nephrology
  • 9.12. Oncology
  • 9.13. Rare Diseases
  • 9.14. Respiratory Disorders

10. Clinical Trial Supply & Logistics Market, by End User

  • 10.1. Introduction
  • 10.2. Contract Research Organisations
  • 10.3. Medical Devices Companies
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Clinical Trial Supply & Logistics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Clinical Trial Supply & Logistics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Clinical Trial Supply & Logistics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. PCM Trials acquires Netherlands-based Clinical Trial Service
    • 14.3.2. Piramal Pharma Solutions Commemorates Opening of its ADC Manufacturing Expansion in Grangemouth, Scotland
    • 14.3.3. Biocair Announces the U.S. Expansion as Part Of Global Growth Strategy
    • 14.3.4. Vaxcyte and Lonza Sign New Commercial Manufacturing Agreement for PCVs
    • 14.3.5. Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site
    • 14.3.6. Signant Health Launches Signant Biotech to Accelerate and Streamline Clinical Development for Emerging Biopharmaceutical Organizations
    • 14.3.7. N-SIDE Introduces Lighthouse, Innovative Software to Shape the Future of Worldwide Clinical Trial Supply Management
    • 14.3.8. Zuellig Pharma and GSK establish vaccine distribution hub in Singapore
    • 14.3.9. Ariceum Therapeutics and Eurofins CDMO Sign a Pharmaceutical Multi-Project Agreement
    • 14.3.10. Vial Announces Strategic Partnership with Royale International Group
    • 14.3.11. Biocair Partners with TrakCel to Improve Visibility in the Supply Chain
    • 14.3.12. IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer
    • 14.3.13. Catalent Starts Construction of USD 20M Expansion at Clinical Supply Facility in Germany
    • 14.3.14. Eurofins BioPharma Product Testing ENCO Expands the U.S. Capabilities Footprint
    • 14.3.15. Calyx Introduces New Clinical Trial Supply Forecasting Service
    • 14.3.16. Catalent Completes Expansion of Singapore Clinical Supply Facility for Increased Temperature-Controlled Capabilities
    • 14.3.17. Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou, China

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET DYNAMICS
  • FIGURE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COMPARATOR SOURCING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COMPARATOR SOURCING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COLD CHAIN DISTRIBUTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COLD CHAIN DISTRIBUTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NON-COLD CHAIN DISTRIBUTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NON-COLD CHAIN DISTRIBUTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MANUFACTURING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PACKAGING, LABELING, & BLINDING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PACKAGING, LABELING, & BLINDING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STORAGE & RETENTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STORAGE & RETENTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BA/ BE STUDIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BA/ BE STUDIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 1, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 1, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 2, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 2, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 3, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 3, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 4, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 4, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CNS & MENTAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CNS & MENTAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ENT DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ENT DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NEPHROLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RARE DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 72. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 73. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 74. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 75. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 76. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 77. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 78. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 79. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 80. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 81. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 82. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 83. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 84. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 85. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 88. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 89. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 90. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 91. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 92. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 93. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 94. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 95. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 96. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 97. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 98. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 99. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 102. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 103. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 104. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 105. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 106. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 107. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 108. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 109. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 110. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 111. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 114. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 115. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 116. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 117. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 118. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 119. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 120. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 121. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 122. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 123. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 126. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 127. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 128. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 129. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 130. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 131. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 132. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 133. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 134. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 135. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 138. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 139. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 140. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 141. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 142. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 143. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 144. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 145. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 146. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 147. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 150. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 151. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 152. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 153. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 154. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 155. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 156. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 171. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 172. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 173. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 174. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 175. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 178. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 179. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 180. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 181. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 182. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 183. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 184. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 185. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 186. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 187. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 190. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 191. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 192. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 193. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 194. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 195. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 196. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 197. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 198. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 199. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 200. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 201. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 202. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 203. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 204. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 205. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 206. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 207. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 208. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 209. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 210. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 211. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 214. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 215. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 216. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 217. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 218. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 219. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 220. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 221. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 222. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 223. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 226. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 227. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 228. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 229. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 230. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 231. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 232. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 233. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 234. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 235. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 238. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 239. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 240. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 241. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 242. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 243. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 244. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 245. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 246. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 247. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 250. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 251. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 252. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 253. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 254. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 255. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 256. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 257. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 258. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 259. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 262. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 263. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 264. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 265. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 266. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 267. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 268. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 269. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 270. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 271. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 274. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 275. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 276. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 277. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 278. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 279. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 280. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 281. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 282. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 283. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 286. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 287. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 288. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 289. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 290. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 291. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 292. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 293. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 294. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 295. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 296. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 297. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 298. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 299. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 300. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAP